For: | Li N, Xu JH, Yu M, Wang S, Si CW, Yu YY. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy. World J Gastroenterol 2015; 21(43): 12421-12429 [PMID: 26604649 DOI: 10.3748/wjg.v21.i43.12421] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i43/12421.htm |
Number | Citing Articles |
1 |
Ahmad Hormati, Maryam Jameshorani, Seyed Saeed Sarkeshikian , Mansureh Molaei, Mahdi Jahangiri, Mohammad Reza Ghadir. Effects of Atorvastatin Alongside Conventional Medical Treatment on Liver Fibrosis and Dysfunction in Patients with Chronic Hepatitis B: A Double-Blinded Clinical Trial. Hepatitis Monthly 2019; (In Press) doi: 10.5812/hepatmon.84656
|
2 |
Antonio Liguori, Mirko Zoncapè, Giovanni Casazza, Philippa Easterbrook, Emmanuel A Tsochatzis. Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2025; 10(4): 332 doi: 10.1016/S2468-1253(24)00437-0
|
3 |
Yusuf Emre Ozdemir, Meryem Sahin Ozdemir, Osman Faruk Bayramlar, Serkan Surme, Sibel Yildiz Kaya, Ridvan Karaali, Ilker Inanc Balkan, Bilgul Mete, Nese Saltoglu, Fehmi Tabak. Long-term follow-up of treatment-naïve HBeAg-negative patients with chronic hepatitis B. Irish Journal of Medical Science (1971 -) 2023; 192(2): 633 doi: 10.1007/s11845-022-03066-y
|